Clinical Trials Browser

Phase 1 × Breast Neoplasms × Tomography, X-Ray Computed × Clear all

NCT04504331 2026-02-12

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Phase 1 Terminated

4 enrolled 11 charts

Breast Neoplasms

NCT02708511 2018-04-05

Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer

Phase 1 Terminated

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms